SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Apollo Hospitals gains on collaborating with Medtronic, Inc

10 Oct 2013 Evaluate

Apollo Hospitals Enterprise is currently trading at Rs. 898.90, up by 11.25 points or 1.27 % from its previous closing of Rs. 887.65 on the BSE.

The scrip opened at Rs. 886.00 and has touched a high and low of Rs. 899.50 and Rs. 885.00 respectively. So far 3626 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1096.15 on 17-May-2013 and a 52 week low of Rs. 727.50 on 10-Oct-2012.

Last one week high and low of the scrip stood at Rs. 932.00 and Rs. 850.50 respectively. The current market cap of the company is Rs. 12479.53 crore.

The promoters holding in the company stood at 34.35% while Institutions and Non-Institutions held 45.34% and 19.52% respectively.

Apollo Hospitals Enterprise has entered into collaboration with Medtronic, Inc., the global leader in medical technology, to bring to market an innovative, affordable and portable hemodialysis system in India. This would help improve access to care for End Stage Renal Disease (ESRD) patients who need Renal Replacement Therapy (RRT). 

This collaboration will leverage a Medtronic-developed technology platform, supported by clinical insight from Apollo envisioning a cost reduction by 10-20 per cent for patients. At present, on an average a patient spends about Rs 1,200 to Rs 2,000 for a dialysis.

Medtronic intends to develop and manufacture key components of this hemodialysis system in India which will be ready for commercial launch in 2016. 

Apollo Hospital Ent. Share Price

7699.05 143.10 (1.89%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×